Pulse pressure, arterial stiffness, and drug treatment of hypertension

Hypertension

Volumn 38, Issue 4, 2001, Pages 914-921

  Van Bortel, Luc M A B ^a   Struijker Boudier, Harry A J ^a   Safar, Michel E ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Antihypertensive agents; Arterial stiffness; Blood pressure; Epidemiology; Pulse pressure

Indexed keywords

ISOSORBIDE DINITRATE; NITRATE; NITRIC OXIDE DONOR;

ANTIHYPERTENSIVE THERAPY; ARTERY DIAMETER; ARTERY WALL; CONFERENCE PAPER; EPIDEMIOLOGICAL DATA; HUMAN; HYPERTENSION; MEAN ARTERIAL PRESSURE; MORBIDITY; MORPHOLOGY; MORTALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULSE PRESSURE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RIGIDITY; RISK FACTOR; STRESS;

EID: 0035723899     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/hy1001.095773     Document Type: Conference Paper

References (85)

1. The natural history of borderline isolated systolic hypertension
2. Pulsatile versus steady component of blood pressure: A cross-sectional analysis and a prospective analysis on cardiovascular mortality
3. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction
4. Is pulse pressure useful in predicting risk for coronary heart disease: The Framingham Heart Study
5. A decrease in diastolic blood pressure combined with an increase in systolic blood pressure is associated with high cardiovascular mortality
6. Distribution and determinants of cardiovascular events during 20 years of successful antihypertensive treatment
7. Therapeutic trials and large arteries in hypertension
8. Aortic distensibility in normotensive untreated and treated hypertensive patients
9. The paradigm has shifted to systolic blood pressure
10. Blood pressure control in the antihypertensive and lipid lowering treatment to prevent heart attack trial
11. Baseline characteristics of the 16,605 patients in the CONVINCE study
12. Antihypertensive therapy with uncontrolled systolic pressure and increased aortic rigidity
13. Blood pressure as a cardiovascular risk factor: Prevention and treatment
14. Measures of blood pressure and myocardial infarction in treated hypertensive patients
15. Ambulatory pulse pressure: A potent predictor of total cardiovascular risk in hypertension
16. Pulse pressure as a risk factor for cardiovascular events in the MRC mild hypertension trial
17. Pulse pressure, not mean pressure, determines cardiovascular risk in older hypertensive patients
18. Impact of aortic stiffness on survival in end-stage renal failure
19. Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease
20. Cardiovascular disease risk profiles
21. Stroke volume/pulse pressure ratio and cardiovascular risk in arterial hypertension
22. Pulse pressure: A predictor of long-term cardiovascular mortality in a French male population
23. Pulse pressure and cardiovascular mortality in normotensives and hypertension
24. Blood pressure, stroke, and coronary heart disease, 2: Short-term reductions in blood pressure. Overview of randomized drug trials in their epidemiological context
25. Risks of untreated and treated isolated systolic hypertension in the elderly: Meta-analysis of outcome trials
26. What does STOP-2 tell us about management of hypertension?
27. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program (SHEP)
28. The role of diastolic blood pressure when treating isolated systolic hypertension
29. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
30. Hypertension Optimal Treatment (HOT) trial
31. The influence of heart rate on augmentation index and central arterial pressure in humans
32. The arterial system in human hypertension
33. Influence of sex on arterial hemodynamics and blood pressure: Role of body height
34. L'hypertension arterielle des amputes traumatiques
35. Vascular growth and hypertension
36. Carotid artery distensibility and distending pressure in hypertensive humans
37. Effects of hypertension on viscoelasticity of carotid and femoral arteries in humans
38. Aortic compliance in human hypertension
39. Influence of age and end-stage renal disease on the stiffness of carotid wall material in hypertension
40. Different mechanisms of endothelial dysfunction with aging and hypertension in rat aorta
41. Anatomic heterogeneity of vascular aging: Role of nitric oxide and endothelin
42. Nitric oxide modulates expression of cell cycle regulatory proteins: A cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation
43. Antihypertensive effects of nitrates in chronic human hypertension
44. Systolic hypertension: Hemodynamic mechanism and choice of antihypertensive treatment
45. Antihypertensive effect of sustained-release isosorbide dinitrate for isolated systolic hypertension in the elderly
46. Treatment of elderly patients with isolated systolic hypertension with isosorbide dinitrate in an asymmetric dosing schedule
47. Hemodynamic effects of vasodilating drugs on the common carotid and brachial circulations of patients with essential hypertension
48. Genetic determination of plasma aldosterone levels in essential hypertension
49. Mechanism of nitrate-induced improvement on arterial compliance depends on vascular territory
50. Short- and long-term effects of antihypertensive drugs on arterial reflections, compliance, and impedance
51. Wave travel in arteries and the design of the cardiovascular system
52. Is it possible to develop drugs that act more selectively on large arteries?
53. Relaxation of vascular smooth muscle by cicletanine in aged Wistar aorta under stress conditions
54. Nebivolol vasodilates human forearm vasculature: Evidence for an L-arginine/NO-dependent mechanism
55. Nitric oxide mediated venodilator effects of nebivolol
56. Antihypertensive treatment and vessel wall properties of large arteries
57. Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells
58. Vascular smooth muscle cell hypertrophy vs hyperplasia: Autocrine transforming growth factor-β1 expression determines growth response to angiotensin II
59. Modifications of the arterial mechanical properties of normotensive and hypertensive rats without arterial pressure changes
60. Angiotensin converting enzyme inhibition prevents the increase in aortic collagen in rats
61. Role of angiotensin II and bradykinin on aortic collagen following converting-enzyme inhibition in spontaneously hypertensive rats
62. Pressure-independent contribution of sodium to large artery structure and function in hypertension
63. Dietary salt increases endothelial nitric oxide synthase and TGF-beta1 in rat aortic endothelium
64. Fixed-dose combination of perindopril with indapamide in spontaneously hypertensive rats: Haemodynamic, biological and structural effects
65. Effect of salt on the vascular lesions of spontaneously hypertensive rats
66. Sodium, survival and the mechanical properties of the carotid artery in stroke-prone hypertensive rats
67. Effects of a chronic high-salt diet on large artery structure: Role of endogenous bradykinin
68. Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats (SHR)
69. Arterial smooth muscle cell phenotype in stroke-prone spontaneously hypertensive rats
70. Resistance and conduit arteries following converting enzyme inhibition in hypertension
71. Comparison of effects of felodipine versus hydrochlorothiazide on arterial diameter and pulse-wave velocity in essential hypertension
72. Arterial stiffness, hydrochlorothiazide and converting enzyme inhibition in essential hypertension
73. Influence of angiotensin-converting enzyme and angiotensin II type I receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients
74. Angiotensin II type 1 receptor gene polymorphism is associated with an increased vascular reactivity in the human mammary artery in vitro
75. Influence of the angiotensin type 1 receptor gene polymorphism on the effects of perindopril and nitrendipine on arterial stiffness in hypertensive individuals
76. Immunohistochemical and biochemical evidence of a cardiovascular mineralocorticoid receptor
77. Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats
78. Association between increased plasma levels of aldosterone and decreased systemic arterial compliance in subjects with essential hypertension
79. Genetic determination of plasma aldosterone levels in essential hypertension
80. Aminoguanidine treatment increases elasticity and decreases fluid filtration of large arteries from diabetic rats
81. Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy
82. Breakers of advanced glycation end-products restore large artery properties in experimental diabetes
83. Cardiovascular disease risk and hormone replacement therapy (HRT): A review based on randomised, controlled studies in postmenopausal women